BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2007
View Archived Issues
Preclinical data from AHA meeting on cardiac ischemia therapies
Read More
Adalimumab lowers uveitis flare rate in ankylosing spondylitis patients
Read More
Further RAPID study data show efficacy of certolizumab in rheumatoid arthritis
Read More
Neuropathic pain reduced with transdermal fentanyl
Read More
NovImmune develops novel mAbs with potential use in septic shock / News in Context
Read More
Recent patents divulge new therapeutic agents for cancer
Read More
Selective antagonists of the SST5 receptor identified at Roche
Read More
Recent Gyeongsang National University patent imparts new treatment for skin hyperpigmentation
Read More
FDA approves Bionomics' IND application for anticancer compound BNC-105
Read More
Research on gene-based reprogramming of human stem cells shows positive results for c-myc
Read More
Ardana reports positive results from clinical trial of its testosterone cream
Read More
Diamyd enters agreement with National Institutes of Health for trial of Diamyd
Read More
Chi-Med to initiate phase IIb trial of HMPL-004 for ulcerative colitis
Read More
The A3AR as putative target of autoimmune disease therapy
Read More
New treatment options for psychotic, depressive and anxiety disorders reported in recent patents
Read More
Schering-Plough reports third quarter 2007 results
Read More
Gilead announces third quarter 2007 results
Read More
Bristol-Myers Squibb and Pierre Fabre terminate license agreement for vinflunine
Read More
ALK-Abello reports positive results from GT-12 phase III clinical study of Grazax in children
Read More
Medicago reports further positive results from preclinical study of H5N1 avian influenza vaccine
Read More
FDA approves Wyeth Pharmaceuticals' Protonix for delayed-release oral suspension
Read More
GW Pharmaceuticals and Otsuka initiate phase II/III clinical trial of Sativex for cancer pain
Read More
FDA accepts for filing Schering-Plough's NDA for asenapine for schizophrenia
Read More
Medivir presents an update on clinical programs for Lipsovir and MIV-701
Read More